Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (342)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
31
2026
191
12.980
 Why?
Anticonvulsants
20
2025
136
8.670
 Why?
Seizures
24
2025
201
6.090
 Why?
Tuberous Sclerosis
8
2025
37
4.190
 Why?
Spasms, Infantile
11
2025
31
4.070
 Why?
Cannabidiol
8
2025
44
3.870
 Why?
Status Epilepticus
6
2021
34
3.220
 Why?
Epilepsies, Myoclonic
5
2024
15
2.980
 Why?
Mutation
16
2023
1331
2.960
 Why?
Deep Brain Stimulation
4
2025
42
2.730
 Why?
Humans
120
2026
52459
2.660
 Why?
Electroencephalography
18
2024
301
2.420
 Why?
Child
45
2026
7195
2.280
 Why?
Intellectual Disability
5
2023
127
2.120
 Why?
Brain
10
2024
1338
2.040
 Why?
Hemiplegia
3
2021
12
1.930
 Why?
Developmental Disabilities
5
2019
125
1.620
 Why?
Epilepsy, Absence
3
2019
11
1.570
 Why?
Magnetic Resonance Imaging
16
2025
1508
1.560
 Why?
Infant
24
2025
3712
1.520
 Why?
Genetic Therapy
2
2025
127
1.430
 Why?
Algorithms
2
2025
673
1.350
 Why?
Tumor Suppressor Proteins
3
2023
127
1.340
 Why?
Neuroaxonal Dystrophies
2
2022
8
1.340
 Why?
Nervous System Malformations
3
2020
16
1.330
 Why?
Folate Receptor 1
2
2022
27
1.310
 Why?
Child, Preschool
23
2026
4046
1.300
 Why?
Infant, Newborn, Diseases
2
2020
56
1.230
 Why?
Epilepsies, Partial
2
2022
15
1.220
 Why?
Ketamine
2
2020
61
1.210
 Why?
Vagus Nerve Stimulation
2
2025
14
1.120
 Why?
Neurocutaneous Syndromes
2
2019
6
1.100
 Why?
Cadherins
2
2019
61
1.080
 Why?
Male
40
2026
26882
1.020
 Why?
Cerebral Arteries
2
2019
30
1.010
 Why?
Epilepsy, Generalized
2
2023
9
0.990
 Why?
Female
36
2026
28286
0.990
 Why?
Vigabatrin
3
2024
3
0.990
 Why?
Sirolimus
2
2017
72
0.970
 Why?
Tic Disorders
1
2026
4
0.970
 Why?
Neurosurgical Procedures
3
2026
134
0.960
 Why?
Angiofibroma
2
2015
5
0.950
 Why?
Facial Neoplasms
2
2015
22
0.930
 Why?
Treatment Outcome
13
2025
5508
0.920
 Why?
Nerve Tissue Proteins
2
2018
201
0.920
 Why?
Valproic Acid
2
2022
35
0.910
 Why?
Stroke
3
2019
527
0.870
 Why?
Fenfluramine
2
2024
7
0.870
 Why?
Randomized Controlled Trials as Topic
2
2024
625
0.850
 Why?
Dioxolanes
2
2024
16
0.850
 Why?
Thalamus
1
2024
35
0.850
 Why?
Pregnanolone
2
2023
6
0.830
 Why?
Adolescent
18
2026
6714
0.810
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.780
 Why?
Quality Improvement
2
2022
226
0.750
 Why?
Aphasia
1
2022
36
0.740
 Why?
Nervous System Diseases
2
2021
96
0.720
 Why?
Chromosome Deletion
3
2019
138
0.720
 Why?
Abnormalities, Multiple
3
2023
164
0.720
 Why?
Emergencies
1
2021
78
0.690
 Why?
Pharmaceutical Preparations
1
2021
73
0.680
 Why?
Angelman Syndrome
1
2020
1
0.670
 Why?
Transition to Adult Care
1
2020
23
0.660
 Why?
Bone Diseases, Developmental
2
2023
17
0.650
 Why?
Tooth Abnormalities
2
2023
13
0.650
 Why?
Immunoglobulins, Intravenous
1
2021
63
0.640
 Why?
Oligonucleotides, Antisense
1
2020
29
0.640
 Why?
Phenobarbital
1
2020
17
0.640
 Why?
Immunologic Factors
1
2021
114
0.630
 Why?
Flunarizine
1
2019
1
0.630
 Why?
Behavioral Symptoms
1
2019
4
0.630
 Why?
Excitatory Amino Acid Antagonists
1
2020
49
0.630
 Why?
Ocular Physiological Phenomena
1
2019
3
0.620
 Why?
Tetrasomy
1
2019
2
0.620
 Why?
Agenesis of Corpus Callosum
2
2018
9
0.610
 Why?
Chromosomes, Human, Pair 5
1
2019
17
0.610
 Why?
Sneddon Syndrome
1
2019
3
0.610
 Why?
Livedo Reticularis
1
2019
5
0.610
 Why?
Calcium Channel Blockers
1
2019
60
0.610
 Why?
Oral Ulcer
1
2019
3
0.610
 Why?
Behcet Syndrome
1
2019
7
0.600
 Why?
Transposases
1
2019
11
0.600
 Why?
Andersen Syndrome
1
2019
1
0.600
 Why?
Hydrocephalus
1
2019
41
0.600
 Why?
Spinal Cord Diseases
1
2019
38
0.600
 Why?
Receptors, GABA-B
1
2019
11
0.590
 Why?
Vitiligo
1
2019
8
0.590
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.590
 Why?
Leukoencephalopathies
1
2019
15
0.590
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.590
 Why?
Edema
1
2019
63
0.590
 Why?
Migraine Disorders
2
2020
45
0.580
 Why?
Physicians
1
2022
237
0.580
 Why?
Cerebral Infarction
1
2018
35
0.580
 Why?
Electron Transport Complex IV
1
2018
24
0.580
 Why?
Cannabinoid Receptor Agonists
1
2019
49
0.580
 Why?
Muscle Weakness
1
2019
45
0.580
 Why?
Optic Atrophy
1
2018
13
0.580
 Why?
Nephrotic Syndrome
2
2017
34
0.580
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.570
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.570
 Why?
Photic Stimulation
1
2018
55
0.570
 Why?
Alopecia
1
2019
38
0.570
 Why?
Shab Potassium Channels
1
2018
2
0.570
 Why?
Brain Edema
1
2018
37
0.560
 Why?
Parents
1
2021
339
0.560
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
30
0.560
 Why?
Artifacts
1
2018
53
0.550
 Why?
Thrombocytopenia
1
2019
93
0.550
 Why?
Myoclonus
1
2018
10
0.550
 Why?
Autoimmune Diseases
1
2019
87
0.550
 Why?
Biomedical Research
1
2021
261
0.550
 Why?
Mitochondrial Diseases
1
2018
44
0.550
 Why?
Neurodegenerative Diseases
1
2018
83
0.540
 Why?
Practice Guidelines as Topic
1
2020
498
0.540
 Why?
Health Knowledge, Attitudes, Practice
1
2021
504
0.520
 Why?
Models, Biological
1
2020
735
0.520
 Why?
Hearing Loss, Sensorineural
1
2018
80
0.520
 Why?
Osteochondrodysplasias
1
2017
14
0.520
 Why?
Immunologic Deficiency Syndromes
1
2017
18
0.520
 Why?
Arteriosclerosis
1
2017
49
0.520
 Why?
Infant, Newborn
6
2024
2876
0.510
 Why?
Carotid Artery Diseases
1
2017
32
0.510
 Why?
Phenotype
2
2021
792
0.510
 Why?
Drug Discovery
1
2017
94
0.510
 Why?
Prenatal Exposure Delayed Effects
1
2018
196
0.490
 Why?
Cafe-au-Lait Spots
1
2016
2
0.490
 Why?
Child Development
1
2018
209
0.490
 Why?
Skin
1
2019
416
0.490
 Why?
Williams Syndrome
1
2016
24
0.480
 Why?
Migraine with Aura
1
2015
4
0.480
 Why?
Erythema Infectiosum
1
2015
3
0.480
 Why?
Corpus Callosum
2
2023
26
0.480
 Why?
Pulmonary Embolism
1
2017
81
0.480
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.480
 Why?
Syndrome
6
2024
247
0.480
 Why?
Sinus Pericranii
1
2015
1
0.480
 Why?
Parvovirus B19, Human
1
2015
16
0.480
 Why?
Toes
1
2015
15
0.470
 Why?
Electrodiagnosis
1
2015
12
0.470
 Why?
SOS1 Protein
1
2015
2
0.470
 Why?
Crying
1
2015
4
0.470
 Why?
Moyamoya Disease
1
2015
7
0.470
 Why?
Hyperventilation
1
2015
8
0.470
 Why?
Iatrogenic Disease
1
2015
25
0.470
 Why?
Tuberculoma
1
2015
1
0.470
 Why?
Epilepsy, Benign Neonatal
1
2015
2
0.470
 Why?
Noonan Syndrome
1
2015
12
0.460
 Why?
Neurologic Examination
1
2015
73
0.460
 Why?
Encephalitis
1
2016
39
0.460
 Why?
Communication
3
2022
255
0.460
 Why?
Ocular Motility Disorders
1
2015
16
0.460
 Why?
Mutism
1
2015
3
0.460
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.460
 Why?
Repressor Proteins
2
2023
150
0.460
 Why?
Retrospective Studies
9
2026
6695
0.450
 Why?
TOR Serine-Threonine Kinases
1
2015
83
0.450
 Why?
Diagnosis, Differential
7
2020
1029
0.450
 Why?
Trisomy
1
2014
35
0.440
 Why?
KCNQ2 Potassium Channel
1
2014
8
0.440
 Why?
Influenza, Human
1
2015
90
0.430
 Why?
Energy Drinks
1
2014
6
0.430
 Why?
Neurology
1
2015
39
0.430
 Why?
Vasoconstriction
1
2014
56
0.430
 Why?
Benzodiazepines
1
2014
71
0.420
 Why?
Osteomyelitis
1
2015
125
0.420
 Why?
Membrane Proteins
1
2016
344
0.410
 Why?
Enzyme Inhibitors
1
2015
378
0.400
 Why?
Sleep
1
2014
191
0.400
 Why?
Palliative Care
2
2026
194
0.390
 Why?
Quality of Life
4
2025
893
0.380
 Why?
Magnetic Resonance Angiography
3
2019
67
0.380
 Why?
Immunosuppressive Agents
3
2019
248
0.370
 Why?
Consensus
2
2025
195
0.360
 Why?
Pediatrics
1
2015
303
0.360
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
126
0.330
 Why?
Clinical Trials as Topic
2
2024
461
0.320
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
131
0.320
 Why?
Caregivers
2
2021
239
0.300
 Why?
Recurrence
3
2019
680
0.300
 Why?
Echinocandins
1
2008
64
0.280
 Why?
Mycoses
1
2008
152
0.270
 Why?
Gastroesophageal Reflux
2
2019
50
0.260
 Why?
Antifungal Agents
1
2008
347
0.240
 Why?
Administration, Topical
2
2015
62
0.230
 Why?
Adult
6
2025
14212
0.230
 Why?
Seizures, Febrile
1
2024
3
0.220
 Why?
Meta-Analysis as Topic
1
2024
39
0.220
 Why?
Magnetoencephalography
1
2025
90
0.220
 Why?
Memory, Short-Term
1
2025
77
0.220
 Why?
Neuropsychological Tests
1
2026
346
0.220
 Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.210
 Why?
Psychosurgery
1
2023
5
0.210
 Why?
Databases, Factual
2
2024
722
0.210
 Why?
Comorbidity
1
2026
637
0.210
 Why?
Laser Therapy
1
2023
74
0.200
 Why?
Speech Disorders
1
2022
17
0.190
 Why?
Ethosuximide
1
2022
5
0.190
 Why?
Clonazepam
1
2022
6
0.190
 Why?
Cluster Analysis
1
2023
236
0.190
 Why?
Electrodes, Implanted
1
2022
37
0.190
 Why?
Stereotaxic Techniques
1
2022
41
0.190
 Why?
Death, Sudden
1
2022
9
0.190
 Why?
GTPase-Activating Proteins
1
2022
24
0.190
 Why?
Concept Formation
1
2021
13
0.180
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.180
 Why?
Freedom
1
2021
3
0.180
 Why?
Folic Acid
1
2022
137
0.180
 Why?
Diazepam
1
2021
18
0.180
 Why?
Drug Interactions
1
2022
198
0.180
 Why?
Fibroma
1
2021
40
0.170
 Why?
Adrenocorticotropic Hormone
2
2022
32
0.170
 Why?
Personal Satisfaction
1
2021
74
0.170
 Why?
Soft Tissue Neoplasms
1
2021
56
0.170
 Why?
Risk Factors
2
2020
3972
0.170
 Why?
Brain Diseases
1
2021
80
0.170
 Why?
Dihydroergotamine
1
2020
4
0.170
 Why?
Transcription Factors
2
2023
570
0.160
 Why?
Mental Disorders
1
2025
427
0.160
 Why?
Perception
1
2021
121
0.160
 Why?
Facies
2
2023
36
0.160
 Why?
Diet Therapy
1
2020
8
0.160
 Why?
Genetic Diseases, Inborn
1
2020
25
0.160
 Why?
Clinical Protocols
1
2020
107
0.160
 Why?
Treatment Failure
1
2020
117
0.160
 Why?
Anesthetics
1
2020
37
0.160
 Why?
Learning
1
2021
158
0.150
 Why?
Leukomalacia, Periventricular
1
2019
12
0.150
 Why?
Muscle Hypotonia
1
2019
23
0.150
 Why?
Chromosomes, Human, Pair 7
1
2019
29
0.150
 Why?
Matrix Attachment Region Binding Proteins
1
2020
38
0.150
 Why?
Ubiquitin-Protein Ligases
1
2020
132
0.150
 Why?
HLA-B51 Antigen
1
2019
2
0.150
 Why?
Qualitative Research
1
2021
365
0.150
 Why?
Analgesics, Non-Narcotic
1
2020
118
0.150
 Why?
Ventriculoperitoneal Shunt
1
2019
28
0.150
 Why?
Craniofacial Abnormalities
1
2019
27
0.150
 Why?
Patient-Centered Care
1
2021
141
0.150
 Why?
Heart Septal Defects, Atrial
1
2019
45
0.150
 Why?
Disease Management
1
2020
185
0.150
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.150
 Why?
Ventricular Premature Complexes
1
2019
7
0.150
 Why?
Microcephaly
1
2019
40
0.150
 Why?
Referral and Consultation
1
2021
288
0.150
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.150
 Why?
Facial Nerve Diseases
1
2018
6
0.150
 Why?
Syncope
1
2019
31
0.150
 Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.140
 Why?
Cerebral Veins
1
2018
17
0.140
 Why?
Facial Paralysis
1
2018
25
0.140
 Why?
Health Personnel
1
2021
255
0.140
 Why?
Anti-Arrhythmia Agents
1
2019
79
0.140
 Why?
Deglutition Disorders
1
2019
76
0.140
 Why?
Acute Disease
1
2019
384
0.140
 Why?
Fatal Outcome
1
2019
193
0.140
 Why?
Fibrinolytic Agents
1
2019
131
0.140
 Why?
Frameshift Mutation
1
2018
18
0.140
 Why?
Video Recording
1
2018
79
0.140
 Why?
Combined Modality Therapy
1
2020
641
0.140
 Why?
Anti-Inflammatory Agents
1
2019
166
0.140
 Why?
Fear
1
2018
84
0.140
 Why?
India
1
2017
60
0.130
 Why?
Cerebellum
1
2018
129
0.130
 Why?
History, 21st Century
1
2017
60
0.130
 Why?
Platelet Aggregation Inhibitors
1
2019
211
0.130
 Why?
History, 20th Century
1
2017
101
0.130
 Why?
Neurotoxicity Syndromes
1
2017
46
0.130
 Why?
Methotrexate
1
2017
76
0.130
 Why?
Pandemics
1
2021
580
0.130
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
90
0.130
 Why?
Animals
3
2022
13485
0.130
 Why?
Anti-Infective Agents
1
2017
106
0.120
 Why?
Aldehyde Dehydrogenase
1
2016
24
0.120
 Why?
Influenza B virus
1
2015
6
0.120
 Why?
Hormones
1
2016
57
0.120
 Why?
Delayed Diagnosis
1
2016
29
0.120
 Why?
Arkansas
1
2021
2014
0.120
 Why?
Chromosomes, Human, Pair 3
1
2015
18
0.120
 Why?
North America
1
2015
75
0.120
 Why?
Cerebral Angiography
1
2015
90
0.110
 Why?
Complementary Therapies
1
2015
23
0.110
 Why?
Antibiotics, Antineoplastic
1
2015
83
0.110
 Why?
Chromosomes, Human, Pair 9
1
2014
20
0.110
 Why?
Brain Waves
1
2014
19
0.110
 Why?
Drug Resistance
1
2015
69
0.110
 Why?
Antiemetics
1
2014
32
0.110
 Why?
Polymerase Chain Reaction
1
2015
458
0.110
 Why?
Headache
1
2014
74
0.110
 Why?
Vomiting
1
2014
71
0.100
 Why?
Glutamine
1
2015
177
0.100
 Why?
Mutation, Missense
1
2014
108
0.100
 Why?
Arginine
1
2015
183
0.100
 Why?
Decision Making, Computer-Assisted
1
2013
3
0.100
 Why?
Analgesics
1
2014
107
0.100
 Why?
Diagnostic Errors
1
2013
69
0.100
 Why?
Evidence-Based Medicine
1
2013
271
0.090
 Why?
Inflammation
1
2016
649
0.090
 Why?
Pregnancy
1
2018
2645
0.090
 Why?
Signal Transduction
1
2017
1724
0.080
 Why?
Antineoplastic Agents
1
2017
1215
0.080
 Why?
Dysentery
1
2009
1
0.070
 Why?
Trichuriasis
1
2009
1
0.070
 Why?
Trichuris
1
2009
1
0.070
 Why?
Anesthesia, Intravenous
1
2008
12
0.070
 Why?
Eosinophils
1
2009
39
0.070
 Why?
Lipopeptides
1
2008
61
0.070
 Why?
Amyloidosis
1
2009
85
0.070
 Why?
Tuberculosis
1
2009
129
0.070
 Why?
Candidiasis
1
2008
112
0.070
 Why?
Aspergillosis
1
2008
122
0.070
 Why?
Inflammatory Bowel Diseases
1
2009
87
0.070
 Why?
Kidney Diseases
1
2009
230
0.060
 Why?
Prospective Studies
2
2023
2436
0.060
 Why?
Clinical Trials, Phase III as Topic
1
2025
49
0.060
 Why?
Observer Variation
1
2024
134
0.050
 Why?
Spasm
1
2024
9
0.050
 Why?
Feedback
1
2024
52
0.050
 Why?
Kaplan-Meier Estimate
1
2025
485
0.050
 Why?
Probability
1
2023
171
0.050
 Why?
Young Adult
2
2025
4349
0.050
 Why?
Neuroimaging
1
2023
91
0.050
 Why?
Pilot Projects
1
2025
725
0.050
 Why?
Potassium Channels
1
2021
31
0.040
 Why?
Cohort Studies
1
2026
1579
0.040
 Why?
Reproducibility of Results
1
2024
1224
0.040
 Why?
Registries
1
2024
639
0.040
 Why?
Administration, Intravenous
1
2020
73
0.040
 Why?
Sleep Stages
1
2020
41
0.040
 Why?
Age of Onset
1
2020
109
0.040
 Why?
Follow-Up Studies
1
2025
2294
0.040
 Why?
Cognition
1
2022
363
0.040
 Why?
Immunohistochemistry
1
2021
977
0.040
 Why?
Aged
1
2025
10243
0.020
 Why?
Internet
1
2013
262
0.020
 Why?
Software
1
2013
281
0.020
 Why?
Middle Aged
1
2025
13136
0.020
 Why?
Mebendazole
1
2009
2
0.020
 Why?
Antinematodal Agents
1
2009
3
0.020
 Why?
Leukemoid Reaction
1
2009
6
0.020
 Why?
Antitubercular Agents
1
2009
88
0.020
 Why?
Colonoscopy
1
2009
105
0.020
 Why?
Prognosis
1
2009
2100
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (342) concept(s)
_
Co-Authors Expand Description
See all (20) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department